Hepatitis E Virus (HEV)
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: closed (25 November 2022) | Viewed by 31969
Special Issue Editors
Interests: viral hepatitis; clinical virology; zoonosis
Special Issues, Collections and Topics in MDPI journals
Interests: viral hepatitis; liver disease; antiviral therapy; vaccine development; animal models
Special Issue Information
Dear Colleagues,
Hepatitis E virus (HEV) is one of the most important causes of viral hepatitis globally. HEV is actually an umbrella term for a large group of variants, many of which can cause human infections. Through multiple transmission routes (food-borne zoonotic, human-to-human, blood-borne), HEV has established niches in various epidemiological settings. The clinical spectrum of hepatitis E ranges from asymptomatic infection to fulminant hepatitis. Extrahepatic manifestations are increasingly recognized and immunocompromised patients are prone to persistent infections.
We are honoured to act as guest editors for this Special Issue entitled ‘Hepatitis E Virus (HEV)’, which seeks to publish high-quality original research and review articles on unanswered questions in the field of hepatitis E pathogenesis, epidemiology, clinical management, and control. Both clinical research and basic research with translational relevance are welcome.
Dr. Siddharth Sridhar
Prof. Dr. Philip Meuleman
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatitis e virus
- epidemiology
- clinical diagnostics
- clinical management
- animal models
- antivirals
- vaccines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.